SAN DIEGO–(BUSINESS WIRE)–

• Gill’s 25 jaar ervaring op het gebied van gezondheid en consumententechnologie in Azië, Europa en het Midden-Oosten zal ResMed’s groeiende, wereldwijd verbonden gezondheidsbedrijven helpen begeleiden
• Tijdens de jaarlijkse aandeelhoudersvergadering maakte Gary W. Pace bekend met pensioen te gaan

ResMed (NYSE: RMD, ASX: RMD), een leider in cloud-aangesloten medische hulpmiddelen en out-of-hospital software-as-a-service zakelijke oplossingen, kondigde vandaag aan dat het ervaren consument en gezondheidszorgmedewerker Harjit Gill heeft gekozen voor de Raad van Bestuur.

Deze persmededeling bevat multimedia. Bekijk de volledige versie hier: https://www.businesswire.com/news/home/20181120005179/en/

Gill werd vorige week door de aandeelhouders verkozen op de jaarlijkse aandeelhoudersvergadering in Sydney, Australië. Ook, aangekondigd op die vergadering, heeft Gary W. Pace zich teruggetrokken uit de raad van bestuur van ResMed’s na het dienen op het sinds juli 1994. De benoeming van mevrouw Gill en de pensionering van Dr. Pace werden beide van kracht op donderdag 15 november.

ResMed Elects Harjit Gill to Its Board of Directors

SAN DIEGO–(BUSINESS WIRE)–

• Gill’s 25 years of health and consumer tech experience across Asia, Europe and the Middle East will help guide ResMed’s expanding global connected health businesses
• Also at annual shareholder meeting, long-serving director Gary W. Pace retired

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, today announced it has elected experienced consumer and healthcare executive Harjit Gill to its Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005179/en/

Harjit Gill, BA (Photo: Business Wire)

Ms. Gill was elected by shareholders at its annual shareholder meeting last week in Sydney, Australia. Also, announced at that meeting, Gary W. Pace has retired from ResMed’s board after serving on it since July 1994. Ms. Gill’s appointment and Dr. Pace’s retirement both took effect Thursday, November 15.

Ms. Gill has more than 25 years’ experience in health and consumer technology products as an executive, investor and regional business leader spanning Asia, Europe and the Middle East. From 1990 to 2015, she worked for Royal Philips as executive vice president and CEO for Philips ASEAN & Pacific, overseeing Healthcare/Lighting and Consumer Lifestyle Products; senior vice president of International Sales; vice president of Asia for Philips Consumer Lifestyle Products; and various other senior roles in Philips Consumer Electronics businesses in the Netherlands, Hong Kong, Dubai and Singapore. From 2015 to 2016, she served as chief operations and marketing officer for HTC, Taiwan. Since 2016, she has been advisor to Delmedica Investments, a Singapore-based company focused on respiratory health and inventors of the X-Halo breath thermometer.

Ms. Gill is also a board director for Apollo Education and Training, a private company providing English teaching in Vietnam, and has held various leadership roles at the Singapore chapter of YPO, which provides growth and networking opportunities to CEOs worldwide.

“I’m very excited to welcome Harjit Gill to ResMed’s Board,” said ResMed Founder and Board Chairman Peter Farrell. “ResMed will greatly benefit from her vast experience, not only in healthcare and consumer technology, but across the many global regions where ResMed continues to expand its reach.

“I’d also like to thank Dr. Gary Pace for his valuable and effective guidance to ResMed during his 24 years of service as a director,” said Farrell, “including during the period of ResMed’s important transformation from medical device company to global leader in connected medical devices and out-of-hospital software.”

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20181120005179/en/

Contacts

For media:
Jayme Rubenstein
+1 858.836.6798
news@resmed.com

For investors:
Amy Wakeham
+1 858.836.5000
investorrelations@resmed.com